CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 115 filers reported holding CYMABAY THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.08 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $4,360,000 | -42.1% | 500,000 | -58.3% | 0.32% | -49.0% |
Q4 2022 | $7,524,000 | +46.2% | 1,200,000 | -18.4% | 0.64% | +60.1% |
Q3 2022 | $5,145,000 | +18.6% | 1,470,000 | 0.0% | 0.40% | +30.1% |
Q2 2022 | $4,338,000 | +26.8% | 1,470,000 | +33.6% | 0.31% | +67.2% |
Q1 2022 | $3,422,000 | -8.0% | 1,100,000 | 0.0% | 0.18% | +33.6% |
Q4 2021 | $3,718,000 | – | 1,100,000 | – | 0.14% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management III, LLC | 1,641,804 | $7,454,000 | 6.54% |
COMMODORE CAPITAL LP | 2,983,513 | $13,545,000 | 5.40% |
Foresite Capital Management IV, LLC | 1,787,094 | $8,113,000 | 0.97% |
Avoro Capital Advisors LLC | 10,300,000 | $46,762,000 | 0.81% |
Boxer Capital, LLC | 4,000,000 | $18,160,000 | 0.62% |
Sio Capital Management, LLC | 562,339 | $2,553,000 | 0.52% |
ACUTA CAPITAL PARTNERS, LLC | 315,341 | $1,432,000 | 0.52% |
CM Management, LLC | 150,000 | $681,000 | 0.51% |
APIS CAPITAL ADVISORS, LLC | 120,000 | $545,000 | 0.50% |
Versant Venture Management, LLC | 543,753 | $2,469,000 | 0.48% |